Pelthos Therapeutics Inc. PTHS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$10.24M+52.7% | -$21.66M-33.4% | -$16.24M-371% | -$3.45M-75.3% | -$1.97M-2.2% | ||
| $469K+37.9% | $340K— | —— | —— | $0— | ||
| $1.91M+6.1% | $1.8M-34.9% | $2.76M+568% | $413.32K-15.0% | $486K-8.3% | ||
| $2.84M— | —— | —— | —— | $0— | ||
| -$156K— | —— | —— | —— | $0— | ||
| $3.16M— | —— | $928.52K-61.2% | $2.4M+239% | $707K+13.8% | ||
| -$1.91M-155% | $3.47M+30.3% | $2.67M+11,177% | $23.64K— | $0+100% | ||
| -$241K— | —— | —— | —— | $0— | ||
| -$498K— | —— | $1.46M+37,078% | -$3.96K+91.9% | -$49K— | ||
| $1.03M— | —— | $679K— | —— | $0— | ||
| $70K— | —— | —— | —— | $0— | ||
| -$163K-75.3% | -$93K— | —— | —— | $0— | ||
| $195K— | $0-100% | $109-99.9% | $164.89K+75.4% | $94K+23.7% | ||
| -$13.13M-110% | -$6.25M+59.0% | -$15.26M-3,312% | -$447.27K+29.2% | -$632K+5.7% | ||
| $194K— | —— | —— | —— | $0— | ||
| —— | $690.25K0.0% | $690.25K0.0% | $690.25K0.0% | $690.25K— | ||
| -$194K+97.6% | -$8M— | —— | —— | $0— | ||
| $0— | $0-100% | $68K-81.9% | $375K+50.0% | $250K+86.6% | ||
| $1.81M— | —— | —— | —— | $0— | ||
| $27.52M+52.7% | $18.02M-32.5% | $26.69M+7,018% | $375K+50.0% | $250K— | ||
| $14.2M+277% | $3.77M-73.4% | $14.19M+19,740% | -$72.27K+81.1% | -$382K— | ||
| $691K— | $0-100% | $250-98.7% | $18.75K— | $0— | ||
| $0— | —— | —— | —— | $0— | ||
| $1.08M-0.4% | $1.08M— | —— | —— | $0— | ||
| $195K— | $0-100% | $109-99.9% | $164.89K+75.4% | $94K+23.7% | ||
| $1.03M+17.6% | $877K+29.2% | $679K— | $0— | $0— | ||
| -$1.2M— | —— | —— | —— | $0— | ||
| $5.2M— | —— | —— | —— | $0— | ||
| $469K— | —— | —— | —— | $0— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $1.85M0.0% | $1.85M0.0% | $1.85M0.0% | $1.85M— | ||
| -$163K-75.3% | -$93K— | —— | —— | $0— | ||
| -$104K— | —— | —— | —— | $0— | ||
| -$498K— | —— | $1.46M+37,078% | -$3.96K+91.9% | -$49K— | ||
| $70K— | —— | —— | —— | $0— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $1.81M— | —— | —— | —— | $0— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $211.25K0.0% | $211.25K0.0% | $211.25K0.0% | $211.25K+293% | ||
| —— | $184.25K0.0% | $184.25K0.0% | $184.25K0.0% | $184.25K-45.9% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| -$241K— | —— | —— | —— | $0— | ||
| -$163K-75.3% | -$93K— | —— | —— | $0— | ||
| $0— | —— | —— | $12.06K-55.3% | $27K— | ||
| $234K— | —— | —— | —— | $0— | ||
| $29.34M— | —— | —— | —— | $0— | ||
| —— | $92.25K0.0% | $92.25K0.0% | $92.25K0.0% | $92.25K— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $13.25K0.0% | $13.25K0.0% | $13.25K0.0% | $13.25K+657% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $1.36M— | —— | —— | —— | $0— | ||
| $0— | —— | —— | —— | $0— | ||
| -$13.32M— | —— | —— | —— | -$632K+56.4% | ||
| -$13.32M— | —— | —— | —— | -$632K+56.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pelthos Therapeutics Inc. generate?
- Pelthos Therapeutics Inc. (PTHS) generated -$35.1M in operating cash flow over the trailing twelve months.
- What is Pelthos Therapeutics Inc.'s free cash flow?
- After $194.0K of capital expenditures, Pelthos Therapeutics Inc.'s free cash flow was -$16.8M over the trailing twelve months.
- Where does Pelthos Therapeutics Inc.'s cash flow data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
